The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.
Receiving a non-melanoma skin cancer diagnosis can feel stressful. In fact, studies show that more than one in three patients find the diagnosis traumatic, with many more experiencing anxiety about what comes next. For many,…
BOCA RATON, Fla., April 26, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that management…
EVP Rick Golin Assumes New Role Bringing Superficial Radio Therapy to International Distributors in Asia, the Americas, Europe and the Middle East BOCA RATON, Fla., April 19, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a…
A keloid is a cutaneous mass that characteristically develops following a dermal injury. The keloid has beset dermatologists and cosmetic surgeons for decades, in view of both its pathological evolution and therapeutic challenges. Classically described…
Tony Perkins is a public school teacher in St. Louis. Mr. Perkins has suffered with keloids on his neck and torso for 15 years. Although keloids are benign growths, the weight of them has caused…
